These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2284475)

  • 1. [Ovarian cancer].
    Vinagre M
    Rev Chil Obstet Ginecol; 1990; 55(1):54-61. PubMed ID: 2284475
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ovarian cancer].
    Sagae S; Mori M
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):179-83. PubMed ID: 11242643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk factors for the development of ovarian carcinoma].
    Malinova M
    Akush Ginekol (Sofiia); 1999; 38(1):57-60. PubMed ID: 11965725
    [No Abstract]   [Full Text] [Related]  

  • 4. [Epidemiology of ovarian cancer].
    Mosgaard BJ; Lidegaard O
    Ugeskr Laeger; 1996 Sep; 158(37):5150-3. PubMed ID: 8848846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of oral contraceptives and risk of cancer].
    Bjørge T; Engeland A
    Tidsskr Nor Laegeforen; 2002 Aug; 122(18):1788-90. PubMed ID: 12362690
    [No Abstract]   [Full Text] [Related]  

  • 6. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
    Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
    Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis.
    Tung KH; Wilkens LR; Wu AH; McDuffie K; Nomura AM; Kolonel LN; Terada KY; Goodman MT
    Am J Epidemiol; 2005 Feb; 161(4):321-9. PubMed ID: 15692075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [High-risk factors in ovarian cancers].
    Li ZX
    Zhonghua Fu Chan Ke Za Zhi; 1987 Jul; 22(4):239-41. PubMed ID: 3311654
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of reproductive factors, oral contraceptive use and selected lifestyle factors with the risk of ovarian borderline tumors: a Danish case-control study.
    Huusom LD; Frederiksen K; Høgdall EV; Glud E; Christensen L; Høgdall CK; Blaakaer J; Kjaer SK
    Cancer Causes Control; 2006 Aug; 17(6):821-9. PubMed ID: 16783610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.
    McGuire V; Felberg A; Mills M; Ostrow KL; DiCioccio R; John EM; West DW; Whittemore AS
    Am J Epidemiol; 2004 Oct; 160(7):613-8. PubMed ID: 15383404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Female genital cancer and life style factors. New discoveries in epidemiological front-line research].
    Wilhelmson B
    Lakartidningen; 1995 Mar; 92(12):1248-55. PubMed ID: 7707768
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
    Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
    Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.
    Riman T; Nilsson S; Persson IR
    Acta Obstet Gynecol Scand; 2004 Sep; 83(9):783-95. PubMed ID: 15315588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer.
    Gross TP; Schlesselman JJ
    Obstet Gynecol; 1994 Mar; 83(3):419-24. PubMed ID: 8127536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial ovarian cancer and the ability to conceive.
    Whittemore AS; Wu ML; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M; Mohle-Boetani J
    Cancer Res; 1989 Jul; 49(14):4047-52. PubMed ID: 2736545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
    Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
    Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial ovarian cancer.
    Elit L
    Can Fam Physician; 2001 Apr; 47():778-84. PubMed ID: 11340759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral contraceptives give long-lasting protection against ovarian cancer. Use of oral contraceptives can explain reduced incidence of ovarian cancer in Sweden].
    Milsom I; Odlind V
    Lakartidningen; 2008 Mar 5-11; 105(10):715-6. PubMed ID: 18422235
    [No Abstract]   [Full Text] [Related]  

  • 19. Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.
    Greer JB; Modugno F; Allen GO; Ness RB
    Obstet Gynecol; 2005 Apr; 105(4):731-40. PubMed ID: 15802398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.